Mind Cure Health (CNSX:MCUR) - Aktienkurs, Nachrichten und Analyse

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

MCUR Aktienübersicht

Mind Cure Health Inc., a life sciences company, develops and commercializes mental health and wellness products in Canada and North America.

Über das Unternehmen

MCUR fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	6/6
Dividends	0/6

Belohnungen

Risikoanalyse

Does not have a meaningful market cap (CA$9M)

Shares are highly illiquid

Makes less than USD$1m in revenue (CA$0)

Shareholders have been diluted in the past year

Mind Cure Health Inc. Wettbewerber

Telecure Technologies

CNSX:TELE

CA$7.6m

nDatalyze

CNSX:NDAT

CA$5.5m

Think Research

TSXV:THNK

CA$24.6m

Avricore Health

TSXV:AVCR

CA$16.5m

Preisentwicklung & Leistung

Summary of all time highs, changes and price drops for Mind Cure Health
Historical stock prices
Current Share Price	CA$0.075
52 Week High	CA$0.085
52 Week Low	CA$0.05
Beta	-0.26
1 Month Change	0%
3 Month Change	n/a
1 Year Change	15.38%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-77.27%

Aktuelle Nachrichten und Updates

Recent updates

Is Mind Cure Health (CSE:MCUR) In A Good Position To Deliver On Growth Plans?

Sep 14

Aktionärsrenditen

	MCUR	CA Healthcare Services	CA Markt
7D	0%	2.6%	-1.4%
1Y	15.4%	80.6%	10.8%

Rendite im Vergleich zur Industrie: MCUR exceeded the Canadian Healthcare Services industry which returned -25.6% over the past year.

Rendite vs. Markt: MCUR exceeded the Canadian Market which returned -4.1% over the past year.

Preisvolatilität

Is MCUR's price volatile compared to industry and market?
MCUR volatility
MCUR Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	12.9%
Market Average Movement	8.4%
10% most volatile stocks in CA Market	16.9%
10% least volatile stocks in CA Market	3.0%

Stabiler Aktienkurs: MCUR has not had significant price volatility in the past 3 months.

Volatilität im Zeitverlauf: Insufficient data to determine MCUR's volatility change over the past year.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2020	n/a	Philip Tapley	www.mindcure.com

Mind Cure Health Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Mind Cure Health im Vergleich zum Marktanteil des Unternehmens?
MCUR grundlegende Statistiken
Marktanteil	CA$8.63m
Gewinn(TTM)	-CA$6.26m
Umsatz(TTM)	n/a

0.0x

Kurs-Umsatz-Verhältnis

-1.4x

Kurs-Gewinn-Verhältnis

Ist MCUR zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
MCUR Gewinn- und Verlustrechnung (TTM)
Einnahmen	CA$0
Kosten der Einnahmen	CA$17.68k
Bruttogewinn	-CA$17.68k
Sonstige Ausgaben	CA$6.24m
Umsatz	-CA$6.26m

Zuletzt gemeldete Gewinne

Feb 28, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.054
Bruttomarge	0.00%
Nettogewinnspanne	0.00%
Schulden/Eigenkapital-Verhältnis	0%

Wie hat sich MCUR auf lange Sicht entwickelt?

Historische Performance und Vergleiche

This company listing is no longer active

MCUR Aktienübersicht

Belohnungen

Risikoanalyse

Mind Cure Health Inc. Wettbewerber

CNSX:TELE

CA$7.6m

CNSX:NDAT

CA$5.5m

TSXV:THNK

CA$24.6m

TSXV:AVCR

CA$16.5m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

LNG Energy Group Inc. completed the acquisition of Mind Cure Health Inc. (CNSX:MCUR) in a reverse merger transaction.

Mind Cure Health Inc. announced that it has received CAD 0.133 million in funding

Less than half of directors are independent

Mind Cure Health Inc. Announces Board Changes

LNG Energy Group Inc signed a binding Letter of Intent to acquire Mind Cure Health Inc. (CNSX:MCUR) in a reverse merger transaction.

High number of new and inexperienced directors

Recent updates

LNG Energy Group Inc. completed the acquisition of Mind Cure Health Inc. (CNSX:MCUR) in a reverse merger transaction.

Mind Cure Health Inc. announced that it has received CAD 0.133 million in funding

Less than half of directors are independent

Mind Cure Health Inc. Announces Board Changes

LNG Energy Group Inc signed a binding Letter of Intent to acquire Mind Cure Health Inc. (CNSX:MCUR) in a reverse merger transaction.

High number of new and inexperienced directors

Mind Cure Health Inc., Annual General Meeting, Dec 07, 2022

High number of new and inexperienced directors

Mind Cure Health Inc. Announces Management Changes

Mind Cure Health Inc Announces Certification of HIPAA Compliance, Bringing iSTRYM Closer to Commercial Deployment

Mind Cure Health Inc Launches Desire Project to Treat Female Hypoactive Sexual Desire Disorder with MDMA-Assisted Psychotherapy

Is Mind Cure Health (CSE:MCUR) In A Good Position To Deliver On Growth Plans?

Mind Cure Health Inc Announces the Release of the Minimum Viable Product Version of iSTRYM

Mind Cure Health Inc. Develops Two Proprietary Ketamine-Enhanced Protocols for Psychedelic-Assisted Psychotherapy

MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

Mind Cure Health Inc. Names Tarik Lebbadi as Chief Operating Officer

Mind Cure Health Inc. Receives Unconditional Ethics Approval from Veritas IRB for Its Integration Protocol Research Study

MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain and Traumatic Brain Injury

Mind Cure Health Inc. Begins the First Stage of Manufacturing Pharmaceutical Grade Ibogaine to Be Used in Preclinical and Clinical Research

New 90-day low: CA$0.51

Mind Cure Health Inc. Appoints Rob Hill to its Board of Directors

MINDCURE Announces Official Release of Nootropic and Adaptogen Products, Available on E-Commerce Platform

Mind Cure Health Inc. Announces the Engagement of Dr. Dan Engle as Mind Cure's Primary Investigator Consultant

Mind Cure Health Inc. Completes Beta Testing of Proprietary Bioinformatics Platform PsyCollage

Mind Cure Health Inc. has completed a Composite Units Offering in the amount of CAD 20.0004 million.

Mind Cure Health Inc. Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category

Mind Cure Health Inc. Announces the Signing of A Non-Binding Letter of Intent (The 'Loi') for Strategic Investment and Commercial Cooperation with Atma Journey Centers Inc

Mind Cure Health Inc. Announces the Release of iSTRYM

Mind Cure Health Inc. Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club

Mind Cure Health Inc. Announces Novel Supplement Product to Address Teen Wellness

Mind Cure Promotes Kelsey Ramsden to President

Mind Cure Health Inc. announced that it expects to receive CAD 3 million in funding

Mind Cure Health Inc. Appoints Ryan Hartwell as Chief Science Officer

Mind Cure Health Inc. Appoints Geoff Belair as Chief Technology Officer

Mind Cure Health Inc. Appoints Wolfram Tetzlaff to Scientific Advisory Board

Mind Cure Health Inc. Appoints Jon Bier to its Advisory Board

Mind Cure Health Inc. Announces the Addition of Dr. Jason Wallach to the Company's Scientific Advisory Board

Mind Cure Health Inc. Announces the Addition of Dan Engle to the Scientific Advisory Board

Mind Cure Announces Kelsey Ramsden as New Chief Operating Officer

Mind Cure Health Inc. Announces Appointment of Alain Roy as Product Development Specialist

Mind Cure Receives Health Canada Authorization to Sell Its Moonbeam Mushroom Products in Canada

Mind Cure Health Inc. has completed an IPO in the amount of CAD 2.6 million.

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

Mind Cure Health Inc.'s Grundlagenzusammenfassung

0.0x

-1.4x

Erträge &amp; Einnahmen

Erträge & Einnahmen